Skip to content

Dr. DE MULDER Raphaël

Active
Private limited companyfounded 2007active for 19 yearsKoninklijkelaan 5, 2600 Antwerp, BelgiumKBO/BCE: BE 0892.165.418
Summary

Dr. DE MULDER Raphaël has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.3m and a net result of €105,809. Equity has been growing by about 36% per year since 2018. Its solvency ranks better than 95% of 3,040 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 19-09-2007 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.251.611.015 2600 Antwerp, since 19-09-2007
Financial year end
31 December
Peppol
Reachable since 22-01-2026

Board and ownership

Last known board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€259,139
▼ 22.0%
Turnover
≈ €500,000
estimated
Profit
€105,809
▼ 52.6%
Equity
€1.3m
▲ 16.5%
Total assets
€1.3m
▲ 16.9%
Staff
≈ 0 FTE
estimated
  • 2025 accounts filed 49 days after the deadline
Net result -53%: other schema
Score breakdownraises riskLast filed accounts filed 49 days late; 3 of the last 3 accounts latelowers riskSector: Human health activities (NACE 86)Equity €1.3m (99.3% of total assets)Figures for financial year 2025 (filed on 18-09-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 53% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 99.3% of total assets
Liquidity 66+2
short-term debt 0.5% · cash 13.0%
Profitability 79-15
return on assets 8.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €120,000 on 30-day terms is acceptable
Short-term debt is 0.5% and cash 13% of total assets. 0.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 46% on liquidity, 24% on profitability and 60% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
raises risk · Last filed accounts filed 49 days late; 3 of the last 3 accounts late
NBB · filings
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Equity €1.3m (99.3% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 18-09-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 49 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-09-2026, 49 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
49 days late
2024
59 days late
2023
31 days late
2022
91 days late
2021
66 days late
2020
54 days late
2019
99 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 64 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 September (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 95% of companies in human healthsector median 59.1% · 3,040 companies 99.3% View
  • Caution: Result fell in 2025different schema filed ▼ 52.6% View
  • Positive: 8 profitable years in a rowprofit 2025: €105,809 8 years View

Recent changes

  1. · Gazette deed Resignation: DE MULDER Raphaël (director)Reappointment: DE MULDER Raphaël (director) · Director discharge: DE MULDER Raphaël (director (not named in the articles))
  2. · Gazette deed Incorporation
All 19 events

Comparable companies

These companies have the same main activity as Dr. DE MULDER Raphaël: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.2m and €1.5m, founded between 2004 and 2009.

CompanyTotal assetsGross margin
Dr. DE MULDER Raphaël Antwerp€1.3m€0.3m
Dr. VAN REGENMORTEL Niels Edegem€1.2m€0.3m
CARDIOLOGIE GILLES DE KEULENAER Boechout€1.3m€0.3m
DR. INGE GEUDENS Oud-Turnhout€1.5m€0.3m
Drs. Roels - Hoste Mechelen€1.3m€0.3m
DR. K. CLAEYSOONE Turnhout€1.2m€0.3m
DR. D. DE CLEEN Schoten€1.2m€0.3m
Full comparison

Key facts about Dr. DE MULDER Raphaël

What is the company number of Dr. DE MULDER Raphaël?
The company number of Dr. DE MULDER Raphaël is 0892.165.418. The VAT number is the same number with BE in front: BE 0892.165.418.
Where is Dr. DE MULDER Raphaël based?
The registered office is at Koninklijkelaan 5, 2600 Antwerp.Company details
What does Dr. DE MULDER Raphaël do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. DE MULDER Raphaël?
Dr. DE MULDER Raphaël is a private limited company (BV).
When was Dr. DE MULDER Raphaël founded?
Dr. DE MULDER Raphaël was founded on 19-09-2007.
Is Dr. DE MULDER Raphaël still active?
Yes, Dr. DE MULDER Raphaël is an active enterprise in the KBO register.
What is the turnover of Dr. DE MULDER Raphaël?
The turnover in financial year 2025 is ≈ €500,000. This figure is estimated from the gross margin of €259,139 and 40 comparable companies (NACE 862). It probably lies between €340,000 and €800,000.Financials
Is Dr. DE MULDER Raphaël profitable?
In financial year 2025, Dr. DE MULDER Raphaël made a profit of €105,809.
Where can I find the annual accounts of Dr. DE MULDER Raphaël?
Dr. DE MULDER Raphaël filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. DE MULDER Raphaël due?
Dr. DE MULDER Raphaël must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.